Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Dec 7;326(21):2141-2149.
doi: 10.1001/jama.2021.20750.

Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial

Affiliations
Randomized Controlled Trial

Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial

Yonathan Freund et al. JAMA. .

Abstract

Importance: Uncontrolled studies suggest that pulmonary embolism (PE) can be safely ruled out using the YEARS rule, a diagnostic strategy that uses varying D-dimer thresholds.

Objective: To prospectively validate the safety of a strategy that combines the YEARS rule with the pulmonary embolism rule-out criteria (PERC) rule and an age-adjusted D-dimer threshold.

Design, settings, and participants: A cluster-randomized, crossover, noninferiority trial in 18 emergency departments (EDs) in France and Spain. Patients (N = 1414) who had a low clinical risk of PE not excluded by the PERC rule or a subjective clinical intermediate risk of PE were included from October 2019 to June 2020, and followed up until October 2020.

Interventions: Each center was randomized for the sequence of intervention periods. In the intervention period (726 patients), PE was excluded without chest imaging in patients with no YEARS criteria and a D-dimer level less than 1000 ng/mL and in patients with 1 or more YEARS criteria and a D-dimer level less than the age-adjusted threshold (500 ng/mL if age <50 years or age in years × 10 in patients ≥50 years). In the control period (688 patients), PE was excluded without chest imaging if the D-dimer level was less than the age-adjusted threshold.

Main outcomes and measures: The primary end point was venous thromboembolism (VTE) at 3 months. The noninferiority margin was set at 1.35%. There were 8 secondary end points, including chest imaging, ED length of stay, hospital admission, nonindicated anticoagulation treatment, all-cause death, and all-cause readmission at 3 months.

Results: Of the 1414 included patients (mean age, 55 years; 58% female), 1217 (86%) were analyzed in the per-protocol analysis. PE was diagnosed in the ED in 100 patients (7.1%). At 3 months, VTE was diagnosed in 1 patient in the intervention group (0.15% [95% CI, 0.0% to 0.86%]) vs 5 patients in the control group (0.80% [95% CI, 0.26% to 1.86%]) (adjusted difference, -0.64% [1-sided 97.5% CI, -∞ to 0.21%], within the noninferiority margin). Of the 6 analyzed secondary end points, only 2 showed a statistically significant difference in the intervention group compared with the control group: chest imaging (30.4% vs 40.0%; adjusted difference, -8.7% [95% CI, -13.8% to -3.5%]) and ED median length of stay (6 hours [IQR, 4 to 8 hours] vs 6 hours [IQR, 5 to 9 hours]; adjusted difference, -1.6 hours [95% CI, -2.3 to -0.9]).

Conclusions and relevance: Among ED patients with suspected PE, the use of the YEARS rule combined with the age-adjusted D-dimer threshold in PERC-positive patients, compared with a conventional diagnostic strategy, did not result in an inferior rate of thromboembolic events.

Trial registration: ClinicalTrials.gov Identifier: NCT04032769.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Laribi reported receiving personal fees from Novartis, Bristol Myers Squibb, Aspen, and AstraZeneca outside the submitted work. Dr Miró reported receiving grants from ISCIII_Spanish Ministry of Health (FIS18/00393) outside the submitted work. Dr Simon reported receiving grants from the French Ministry of Health, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Eli Lilly, GlaxoSmithKline, Novartis, and Sanofi; personal fees from AstraZeneca, Ablative Solutions, Bayer, Novartis, Sanofi, and 4Living Biotech; and fees for conferences, counseling, and/or research grants from Merck Sharp & Dohme, Amgen, and Sanofi outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Diagnostic Strategy for Pulmonary Embolism (PE)
YEARS score ranges from 0 to 3, 1 point per item: PE is the most likely diagnosis, hemoptysis, and clinical sign of deep vein thrombosis. Chest imaging included computed tomography pulmonary angiography or pulmonary ventilation/perfusion scan.
Figure 2.
Figure 2.. Patient Flow Diagram
ED indicates emergency department. aOne of the patients who withdrew consent was diagnosed with a pulmonary embolism on day 0 and, therefore, did not meet the primary end point.

Comment in

References

    1. Raja AS, Ip IK, Prevedello LM, et al. . Effect of computerized clinical decision support on the use and yield of CT pulmonary angiography in the emergency department. Radiology. 2012;262(2):468-474. doi:10.1148/radiol.11110951 - DOI - PMC - PubMed
    1. Freund Y, Cachanado M, Aubry A, et al. ; PROPER Investigator Group . Effect of the pulmonary embolism rule-out criteria on subsequent thromboembolic events among low-risk emergency department patients: the PROPER randomized clinical trial. JAMA. 2018;319(6):559-566. doi:10.1001/jama.2017.21904 - DOI - PMC - PubMed
    1. Abdelaal Ahmed Mahmoud M Alkhatip A, Donnelly M, Snyman L, et al. . YEARS algorithm versus Wells’ score: predictive accuracies in pulmonary embolism based on the gold standard CT pulmonary angiography. Crit Care Med. 2020;48(5):704-708. doi:10.1097/CCM.0000000000004271 - DOI - PubMed
    1. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med. 2011;171(9):831-837. doi:10.1001/archinternmed.2011.178 - DOI - PMC - PubMed
    1. van der Pol LM, Dronkers CEA, van der Hulle T, et al. . The YEARS algorithm for suspected pulmonary embolism: shorter visit time and reduced costs at the emergency department. J Thromb Haemost. 2018;16(4):725-733. doi:10.1111/jth.13972 - DOI - PubMed

Publication types

MeSH terms

Substances

Associated data